1. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392:1923–1994.
2. Korean Society Hypertension (KSH). Hypertension Epidemiology Research Working Group. Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens. 2018; 24:13.
Article
3. Lee H, Park S, Kim HC. Temporal and geospatial trends of hypertension management in Korea: a nationwide study 2002-2016. Korean Circ J. 2019; 49:e36.
Article
4. Shin J, Park JB, Kim KI, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology and diagnosis of hypertension. Clin Hypertens. 2015; 21:1.
Article
5. Shin J, Park JB, Kim KI, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertension. Clin Hypertens. 2015; 21:2.
Article
6. Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea national Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43:69–77.
Article
7. Kim Y. The Korea National Health and Nutrition Examination Survey (KNHANES): current status and challenges. Epidemiol Health. 2014; 36:e2014002.
Article
8. Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form. J Korean Acad Fam Med. 2007; 28:532–541.
9. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Geneva: World Health Organization;2000.
10. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310:959–968.
Article
11. Bavishi C, Goel S, Messerli FH. Isolated systolic hypertension: an update after SPRINT. Am J Med. 2016; 129:1251–1258.
Article
12. Fang J, Madhavan S, Cohen H, Alderman MH. Isolated diastolic hypertension. A favorable finding among young and middle-aged hypertensive subjects. Hypertension. 1995; 26:377–382.
13. Nielsen WB, Lindenstrøm E, Vestbo J, Jensen GB. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens. 1997; 10:634–639.
Article
14. Leonetti G, Cuspidi C, Facchini M, Stramba-Badiale M. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure? J Hypertens Suppl. 2000; 18:S13–20.
15. Böhm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017; 389:2226–2237.
Article
16. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018; 71:e127–248.
17. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311:507–520.
18. Hense HW, Maziak W, Heidrich J. Why is blood pressure control unsatisfactory--or is it? Nephrol Dial Transplant. 2002; 17:1547–1550.
Article
19. Izumi Y, Matsumoto K, Ozawa Y, et al. Effect of age at menopause on blood pressure in postmenopausal women. Am J Hypertens. 2007; 20:1045–1050.
Article
20. Maas AH, Franke HR. Women's health in menopause with a focus on hypertension. Neth Heart J. 2009; 17:68–72.
Article
21. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000; 36:594–599.
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143–3421.
23. Adab P, Pallan M, Whincup PH. Is BMI the best measure of obesity? BMJ. 2018; 360:k1274.
Article
24. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012; 97:2482–2488.
Article
25. Chirinos JA, Franklin SS, Townsend RR, Raij L. Body mass index and hypertension hemodynamic subtypes in the adult US population. Arch Intern Med. 2009; 169:580–586.
Article
26. Grotto I, Huerta M, Sharabi Y. Hypertension and socioeconomic status. Curr Opin Cardiol. 2008; 23:335–339.
Article
27. Lee CJ, Ryu J, Kim HC, et al. Clinical benefit of treatment of stage-1, low-risk hypertension. Hypertension. 2018; 72:1285–1293.
Article
28. Kim W, Kim S. Women's alcohol use and alcoholism in Korea. Subst Use Misuse. 2008; 43:1078–1087.
Article
29. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303:2043–2050.
Article